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ABSTRACT 
On March 11, 2020, Miami-Dade County had its first diagnosed case of COVID-19 and quickly     
became the top hotspot of COVID-19 cases in Florida.  Hospitals were challenged to find effective 
treatments to combat the virus. A collaborative effort between Doctors Hospital and Boca Raton    
Regional Hospital established a robust convalescent plasma program for critically ill patients diag-
nosed with COVID-19 within Baptist Health South Florida. 
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INTRODUCTION 
On March 11, 2020, Miami Dade County 
had its first diagnosed case of COVID-19.  Soon 
after, the county would be known as one of the 
top hotspots for COVID-19 cases in the state of 
Florida (Florida Health, 2020). As of May 15, 
2020, nearly 15,000 Miami-Dade County resi-
dents were diagnosed with COVID-19, with 
close to 2,500 residents requiring hospitalization 
and 535 COVID-19 related deaths reported by 
the Florida Department of Health (Florida De-
partment of Health, 2020). As COVID-19 cases 
continued to spread throughout the county, hos-
pitals were challenged to stabilize, treat, and 
support patients the best they could. Treatment 
methods for critically ill patients have included 
therapies such as: hydroxychloroquine, steroids, 
remdesivir, stem cell therapy, and convalescent 
plasma. Different studies, published globally, 
within the past few months, would try to show 
the risks and benefits of using such therapies 
until a targeted treatment or vaccine is estab-
lished to fight COVID-19. The FDA would grant 
emergency authorization for such treatments, in 
the meantime. 
Historically, convalescent plasma has been 
used to treat infections such as rabies, measles, 
polio and other pathogens and dates back to over 
a century when medications or vaccines were not 
readily available to treat or prevent certain out-
breaks (American Society of Hematology, 2020; 
Rubin, 2020). Recently, the FDA has provided 
recommendations for emergency use of conva-
lescent plasma to treat critically ill patients diag-
nosed with COVID-19 (US Food and Drug    
Administration, 2020). The concept behind con-
valescent plasma is to take antibody rich plasma 
from a person who has recovered from COVID-
19 and administer it to a patient who is critically 
ill with the same infection. It is believed the anti-
body rich plasma would passively give patients 
the antibodies necessary to help combat the virus 
(American Society of Hematology, 2020). The 
purpose of this initiative was to establish a pro-
gram to facilitate the donation and transfusion of 
convalescent plasma to critically ill patients   
diagnosed with COVID-19.  
 
COVID-19 INITIATIVE 
 Doctors Hospital in Coral Gables in collabo-
ration with Boca Raton Regional Hospital in 
Palm Beach County, established a convalescent 
plasma donor program within Baptist Health, in 
partnership with One Blood. Lincoln Mendez, 
CEO of Boca Raton Regional Hospital was the 
CEO leading the project in collaboration with 
Diane Amado-Tate, CNO of Doctors Hospital, 
and Becky Montesino-King, DNP, RN, NEA-
BC, CENP. The planning of the convalescent 
plasma program spanned across multiple depart-
ments. Doctors Hospital and Boca Raton Re-
gional Hospital served as the donor/recipient 
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10 Baptist Health South Florida 
processing centers to facilitate screening and 
matching of donors and recipients. One Blood 
facilitated the plasma collection and Baptist 
Health hospitals completed the process by trans-
fusing the antibody rich plasma to critically ill 
patients diagnosed with COVID-19. 
Nurse Navigators were appointed for the two 
regions of Baptist Health and were critical in fa-
cilitating the program. Nurse Navigator, Edwina 
Brathwaite, PhD, MSN/Ed, MS/HSA, RN-BC, 
Director of Nursing Practice Management, Dia-
betes, and Wound Care at Doctors Hospital, with 
supporting physician Dr. J. Perez Fernandez, 
Medical Director at Baptist Hospital of Miami, 
facilitated the process for the South Region and 
Nurse Navigator, Maureen Avella, RN Manager 
of the Cardiac Catherization Lab at Boca Raton 
Regional Hospital, with supporting physician Dr. 
S. Fahmy, CMIO at Boca Raton Regional Hospi-
tal, facilitated the North Region. The Nurse Navi-
gators managed the physician,      patient, and 
donor process to ensure FDA recommendations 
were followed.   
 
CONCLUSION 
Leadership support, interprofessional collab-
oration, regularly scheduled meetings, adaptabil-
ity to changing circumstances and the collective 
effort of all involved led to a robust COVID-19 
convalescent plasma program at Baptist Health. 
Through this initiative, all identified patients at 
the time of this manuscript who were eligible to 
receive convalescent plasma have been matched 
with donors. The overwhelming response of the 
local community to donate antibody rich plasma 
to critically ill patients with COVID-19 was   
inspiring. The program is now currently part of 
an expanded access program facilitated by the 
Mayo Clinic and is being evaluated for efficacy.    
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